The expression of p53 protein was increased by OBP-702 treatment in both p53-intact (SW48, RKO) and p53-mutant (Colo320DM, SW620, HT29, DLD-1) CRC cells (Figs 5 and S4–S6). The gene discussed is TP53; the disease is colorectal carcinoma.